DFM STUDENT SYLLABUS - Flipbook - Page 44
Integration with Organic Acids Testing (OAT)
560
Microbial Metabolites
560
Mitochondrial Function
560
Neurotransmitter Metabolism
561
Nutritional Status
561
Integration with Comprehensive Stool Analysis
561
Large Intestinal Microbiome
561
Digestive Function
561
Beneficial Bacteria Levels
561
Case Examples: Array 22 in Clinical Practice
561
Case 1: IBS with Predominant Bloating
561
Array 22 Results
561
Integration with Other Testing
562
Intervention
562
Outcome
562
Case 2: Post-Infectious IBS with Systemic Symptoms
562
Array 22 Results
562
Integration with Other Testing
563
Intervention
563
Outcome
563
Monitoring and Retesting
563
Retesting Timeline
563
Progress Indicators
563
Persistent Abnormalities
564
Conclusion: The Value of Immune Assessment in SIBO and IBS
564
References
564
When to Use Organic Acids Testing, BiomeFX, and Cyrex Array 22: A Clinical Guide
569
Introduction
569
Organic Acids Testing (OAT)
569
Overview and Mechanism
569
Primary Clinical Applications
570
Suspected Metabolic Dysfunction
570
43
